KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd (MGRC) expects its acquisition target MPath Sdn Bhd to become its main earnings driver.
MGRC yesterday obtained shareholders’ approval to acquire the remaining 50% in MPath for RM11.5mil which will be completed by end of this month.
Already a subscriber? Log in.
Subscribe to win RM50 Touch 'n Go e-Voucher! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!